본문 바로가기

Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
SCIENTIFIC REPORTS8 · 2018
피인용
Web of Science 25Scopus 27
FWCI (Scopus)
0.54
JCR IF
JCR 2017 4.122
ISSN
2045-2322

저자

  1. 김은경제1저자Department of Integrated Biological Science, Pusan National University, Pusan, South Korea
  2. 남제현Department of Integrated Biological Science, Pusan National University, Pusan, South Korea
  3. 장우철Department of Biology Education, Pusan National University, Pusan, South Korea
  4. 이스마일Department of Molecular Biology, Pusan National University, Pusan, South Korea
  5. Okhlopkova, Zhanna M.Department of Biology, North-Eastern Federal University, Yakutsk, Russian Federation
  6. Olennikov, DaniilInstitute of General and Experimental Biology, Ulan-Ude, Russian Federation
  7. Chirikova, Nadezhda K.Department of Biology, North-Eastern Federal University, Yakutsk, Russian Federation
  8. 김상우교신저자Department of Integrated Biological Science, Pusan National University, Pusan, South Korea

초록

Angelica gigas Nakai (AGN) is an oriental traditional medicine to treat anemia, dysmenorrhea, and migraine. However, its anti-lymphoma effect is yet to be tested. Here, we demonstrated that AGN and its major component decursin target Myc to suppress lymphomagenesis in vitro and in vivo. AGN inhibited cell viability in multiple B lymphoma cells, while sparing normal splenocytes and bone marrow cells. Increased cleaved PARP level and caspase 3/7 activity and the repression of survival-promoting AKT/mTOR and MAPK pathways downstream of BCR, were responsible for the pro-apoptotic effects of AGN. We found that Myc, a prominent downstream target of these signaling pathways, contributes to AGN-induced cell death. Moreover, co-treatment with AGN and a Myc inhibitor, JQ1 or 10058-F4 yielded synergistic cytotoxic activities against cancer cells with markedly reduced Myc expression. AGN downregulated Myc expression and suppressed tumorigenesis in E mu-myc transgenic mice. The proapoptotic activities of AGN were recapitulated by decursin, indicating that the anti-tumor effect of AGN was mainly caused by decursin. These findings suggest that AGN and decursin possess potent anti-lymphoma activity, and combination therapies with AGN/decursin and a Myc inhibitor to target Myc more efficiently could be a valuable avenue to explore in the treatment of B-cell lymphoma.

키워드

NON-HODGKINS-LYMPHOMAKOREAN ANGELICATRANSGENIC MICEINHIBITIONRECEPTORCANCERMECHANISMSRESISTANCEDRIVENPROTEINS

식별자

Scopus EID
2-s2.0-85049907720
WoS UID
000438343600100